Conclusion
Fluoroquinolone-associated tendon disruption, including rupture, is well described in the literature. Although the Achilles tendon is the most susceptible site, other tendons may be affected. Typically, spontaneous tendon rupture occurs during or shortly after a course of therapy, but symptoms may occur months after taking fluoroquinolones. Whether fluoroquinolones should be used in patients with a history of tendon problems or with risk factors for the development of tendon ruptures depends on the seriousness of the infection and the alternatives available. Awareness of the association between tendon disorders and fluoroquinolones may lead to enhanced surveillance, which should be extended to sites beyond the Achilles tendon and to periods of months after a course of these antibiotics.
Reprint requests to J. Michael Casparian, MD, University of Kansas Medical Center, Division of Dermatology, 4023 Wescoe, 3901 Rainbow Blvd, Kansas City, KS 66160-7319.
South Med J. 2000;93(5) © 2000 Lippincott Williams & Wilkins
Cite this: Quinolones and Tendon Ruptures - Medscape - May 01, 2000.
Comments